Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of telaprevir triple therapy on intrahepatic immune mechanisms in chronic hepatitis C
2011-005636-26Phase 4Active
- Sponsor
- Foundation for Liver Research
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of telaprevir in hepatitis C virus infection, sponsored by Foundation for Liver Research. Primary endpoint: Sustained virological response (SVR24). Started Dec 2011; status: active.
02
Drugs
telaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2011-005636-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005636-26.